Pure Global AI
NCT06011395Enrolling by invitation

Smart Watch Insights to Prevent Exacerbations and Recurrence - Health Study: SWIPER-HEALTH

Imperial College LondonClinicalTrials.govdeviceDevice trial
Study focus
Drug/Device/Intervention
Smartwatch
Study type
Observational
Intervention type
device
Sponsor & location
Primary sponsor
Imperial College London
Location
London, United Kingdom
Timeline & enrollment
Phase
N/A
Start date
Aug 30, 2023
End date
Aug 30, 2025
Enrollment
1800 participants
Primary outcome

Uptake of cardiac rehabilitation

Summary

Aims of the study:
 
 - To measure the rate of completion of a digital cardiac rehabilitation programme at
 Imperial College Healthcare NHS Trust (ICHNT)
 
 - To measure the health economic impact of a digital cardiac rehabilitation programme at
 ICHNT
 
 Any adult patient eligible for ICHNT cardiac rehabilitation (CR) programmes is eligible to
 participate. Participants will receive a commercially available smart watch and be asked to
 wear the device as much as possible. In addition, they will be asked to download a smartphone
 application called 'Imperial Healthy Hearts', which displays movement and information on
 heart rate, breathing and oxygen levels to both the participant and the research team
 (digital data). The Healthy Hearts app also allows the direct care team to provide
 educational materials to patients as part of their routine care.
 
 The clinical content and structure of the CR programme is determined by the clinical CR team,
 and does not deviate from established local and national standards and practices.
 
 Researchers will capture physiological data such as heart rate, respiratory rate, blood
 pressure (where available) and oxygen saturation (where available) via the Healthy Hearts
 platform. Researchers will also capture clinical information from the electronic health
 record, and will compare CR programme uptake and completion rates with historical data and
 national targets.

ICD-10 classifications
Cardiovascular disease, unspecifiedHypertensive heart diseaseOther ill-defined heart diseasesHeart disease, unspecifiedObservation for other suspected cardiovascular diseases
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06011395
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06011395 through Pure Global AI's free database. This phase not specified trial is sponsored by Imperial College London and is currently Enrolling by invitation. The study focuses on Cardiovascular Diseases. Target enrollment is 1800 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.